Invention Grant
- Patent Title: Oligomer-protein tyrosine kinase inhibitor conjugates
-
Application No.: US13264519Application Date: 2010-04-19
-
Publication No.: US08530492B2Publication Date: 2013-09-10
- Inventor: Jennifer Riggs-Sauthier , Wen Zhang
- Applicant: Jennifer Riggs-Sauthier , Wen Zhang
- Applicant Address: US CA San Francisco
- Assignee: Nektar Therapeutics
- Current Assignee: Nektar Therapeutics
- Current Assignee Address: US CA San Francisco
- Agent Timothy A. Marquart
- International Application: PCT/US2010/001162 WO 20100419
- International Announcement: WO2010/120386 WO 20101021
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505
Abstract:
The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.
Public/Granted literature
- US20120071491A1 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates Public/Granted day:2012-03-22
Information query
IPC分类:
